ReviewFrontiers in immunology2025
Navigating challenges in human pluripotent stem cell-derived islet therapy for type 1 diabetes.
Mohammed Usama et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it